TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
New tuberculosis study findings recently were published by A.G. Rosastaraco and co-researchers
May 12th, 2009
"CD11c is involved in Mycobacterium tuberculosis phagocytosis by human macrophages. CD I I c has not been evaluated during antituberculosis (anti-TB) treatment," scientists in Monterrey, Mexico report. "CD 1 1 c expression was evaluated on monocytes from peripheral blood leukocytes of pulmonary TB (PTB) patients and healthy controls by flow cytometry, whereas CD11c/Arg47Trp polymorphism was analyzed using polymerase chain reaction-restriction fragment length polymorphism. PTB patients had increased levels of CD11c on blood monocytes as compared to healthy controls. CD11c levels decreased in response to anti-TB treatment," wrote A.G. Rosastaraco and colleagues. ...
Source: TB & Outbreaks Week (2009-05-12)
|
